As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...